{"sourcedb":"DevicePMAs@therightstef","sourceid":"P030002_S004","text":"Approval for the following modifications to the physician's labeling: change in the model number and trade name; change in directions for use to facilitate proper insertion and orientation of the lens; and, change in the existing recommendations for maximizing patient outcomes.  The device, as modified, will be marketed under the trade name crystalens se (model at-45 se) and is indicated for primary implantation in the capsular bag of the eye for the visual correction of aphakia secondary to the removal of a cataractous lens in adult patients with and without presbyopia.  The crystalens se (model at-45 se) provides approximately one diopter of monocular accommodation which allows for near, intermediate, and distance vision without spectacles.","project":"consensus_PMA_Age_Indications"}